COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 1002: Articles 10011-10020  | Next

Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
Bajwa, H. M., Novak, F., Nilsson, A. C., Nielsen, C., Holm, D. K., Oestergaard, K., Witt, A. H., Byg, K.-E., Johansen, I. S., Mittl, K., Rowles, W., Zamvil, S., Bove, R., Sabatino, J. J., Sejbaek, T.
10.1101/2022.01.27.22269944 — Posted: 2022-01-28
Who was wearing a mask in 2021? Update on gender-, age-, and location-related differences during the COVID-19 pandemic
Haischer, M. H., Beilfuss, R. N., Hart, M. R., Opielinski, L., Schmit, E., Wrucke, D., Zhao, H., Uhrich, T. D., Hunter, S. K.
10.1101/2022.01.18.22269479 — Posted: 2022-01-28
Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions
Parker, E., Anderson, C., Zeller, M., Tibi, A., Havens, J. L., Laroche, G., Benlarbi, M., Ariana, A., Robles-Sikisaka, R., Latif, A., Watts, A., Awidi, A., Jaradat, S. A., Gangavarapu, K., Kurzban, E., Matteson, N. L., Han, A. X., Hughes, L. D., McGraw, M., Spencer, E., Nicholson, L., Khan, K., Suchard, M. A., Wertheim, J. O., Wohl, S., Cote, M., Abdelnour, A., Andersen, K. G., Abu-Dayyeh, I.
10.1101/2022.01.27.22269922 — Posted: 2022-01-28
Evaluation of the CD4+ T cell response to SARS-CoV-2 infection and cross reactivity to beta variant in children of all ages
Paul, K., Sibbertsen, F., Weiskopf, D., Luetgehetmann, M., Barroso, M., Danecka, M. K., Glau, L., Hecher, L., Hermann, K., Kohl, A., Oh, J., Schulze zur Wiesch, J., Sette, A., Tolosa, E., Vettorazzi, E., Woidy, M., Zapf, A., Zazara, D. E., Mir, T. S., Muntau, A. C., Gersting, S. W., Dunay, G. A.
10.1101/2022.01.27.22269976 — Posted: 2022-01-28
Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations
Zobrist, S., Oliveira-Silva, M., Vieira, A. M., Bansil, P., Gerth-Guyette, E., Leader, B. T., Golden, A., Slater, H., Cruz, C. D. d. L., Garbin, E., Sagalovsky, M., Pal, S., Gupta, V., Wolansky, L., Dall Acqua, D. S. V., Naveca, F. G., Nascimento, V. A. d., Villalobos Salcedo, J. M., Drain, P. K., Costa, A. D. T., Domingo, G. J., Pereira, D.
10.1101/2022.01.27.22269904 — Posted: 2022-01-28
Analysis of Fatality Impact and Seroprevalence Surveys in a Community Sustaining a SARS-CoV-2 Superspreading Event
Richter, E., Liebl, D., Schulte, B., Lehmann, N., Fuhrmann, C., Joeckel, K.-H., Ioannidis, J., Streeck, H.
10.1101/2022.01.26.22269805 — Posted: 2022-01-28
SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second and third wave were often unconnected
Stange, M., Wuerfel, E., Peter, J. K., Seth-Smith, H., Roloff, T., Gsponer, S., Mari, A., Cabrera Gil, B., Lebrand, A., Wegner, F., Heininger, U., Bielicki, J., Tschudin Sutter, S., Stadler, T., Leuzinger, K., Hirsch, H. H., Ledergerber, M., Fuchs, S., Egli, A.
10.1101/2022.01.26.22269824 — Posted: 2022-01-28
Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases
Dayam, R. M., Law, J. C., Goetgebuer, R. L., Chao, G. Y., Abe, K. T., Sutton, M., Finkelstein, N., Stempak, J. M., Pereira, D., Croituru, D., Acheampong, L., Rizwan, S., Rymaszewski, K., Milgrom, R., Ganatra, D., Batista, N. V., Girard, M., Lau, I., Law, R., Cheung, M. W., Rathod, B., Kitaygorodsky, J., Samson, R., Hu, Q., Haroon, N., Inman, R. D., Piguet, V., Chandran, V., Silverberg, M. S., Gingras, A.-C., Watts, T. H.
10.1101/2022.01.26.22269856 — Posted: 2022-01-28
General practitioner wellbeing during the COVID-19 pandemic: a qualitative interview study
Jefferson, L. A., Heathcote, C., Bloor, K.
10.1101/2022.01.26.22269874 — Posted: 2022-01-28
A model-based approach to improve intranasal sprays for respiratory viral infections
Basu, S., Akash, M. M. H., Lao, Y., Balivada, P. A., Ato, P., Ka, N. K., Mituniewicz, A., Silfen, Z., Suman, J., Chakravarty, A., Joseph-McCarthy, D.
10.1101/2022.01.26.22269854 — Posted: 2022-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).